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Abstract
Background: This study was aimed to evaluate antioxidant and α-glucosidase inhibitory activity, with a subsequent
analysis of total phenolic and total flavonoid content of methanol extract and its derived fractions from
Clinacanthus nutans accompanied by comprehensive phytochemical profiling.
Methods: Liquid-liquid partition chromatography was used to separate methanolic extract to get hexane, ethyl acetate,
butanol and residual aqueous fractions. The total antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazy
(DPPH) radical scavenging and ferric reducing antioxidant power assay (FRAP). The antidiabetic activity of methanol
extract and its consequent fractions were examined by α-glucosidase inhibitory bioassay. The chemical profiling was
carried out by gas chromatography coupled with quadrupole time-of-flight mass spectrometry (GC Q-TOF MS).
Results: The total yield for methanol extraction was (12.63 ± 0.98) % (w/w) and highest fractionated value found for
residual aqueous (52.25 ± 1.01) % (w/w) as compared to the other fractions. Significant DPPH free radical scavenging
activity was found for methanolic extract (63.07 ± 0.11) % and (79.98 ± 0.31) % for ethyl acetate fraction among all the
fractions evaluated. Methanol extract was the most prominent in case of FRAP (141.89 ± 0.87 μg AAE/g) whereas most
effective reducing power observed in ethyl acetate fraction (133.6 ± 0.2987 μg AAE/g). The results also indicated a
substantial α-glucosidase inhibitory activity for butanol fraction (72.16 ± 1.0) % and ethyl acetate fraction (70.76 ± 0.49) %.
The statistical analysis revealed that total phenolic and total flavonoid content of the samples had the significant
(p < 0.05) impact on DPPH free radical scavenging and α-glucosidase inhibitory activity.
Conclusion: Current results proposed the therapeutic potential of Clinacanthus nutans, especially ethyl acetate and
butanol fraction as chemotherapeutic agent against oxidative related cellular damages and control the postprandial
hyperglycemia. The phytochemical investigation showed the existence of active constituents in Clinacanthus nutans
extract and fractions.
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Background
The chemotherapeutic uses of medicinal plants are a re-
sult of ancient people’s belief in their protective effects.
Many plants have abundant active secondary metabolites
that exhibit certain pharmacological effects in humans.
Thus plant based traditional remedies have been devel-
oped from these chemotherapeutic agents to prevent
certain ailments [1]. These active constituents are varied
in their chemical structure, chemical composition, protect-
ive activity, and mode of action, hence, medicinal herbs
have been used in traditional medicine. Antioxidant-rich
natural products in the form of herbal formulations are
able to interrupt cellular damage, mainly through the
mechanism of free radical scavenging [2, 3]. Free radical
causes oxidative stress related-complications in the human
body owing to a physiological imbalance of free radicals
and antioxidants, which is related to the impairment of
primary metabolites, and consequently result in a number
of health impediments [4, 5]. Phenolic and flavonoid
compounds are the most common antioxidant metabolites
in plants and include saponins, alkaloids, coumarins,
tannins, lignin, terpenoids, stilbenes, quinones, amines and
betalains [6, 7]. These compounds are important active nat-
ural products, which possess various biological actions, such
as anti-diabetic, anti-inflammatory, hepatoprotective, anti-
allergic, anti-carcinogenic, anti-thrombotic, anti-microbial ac-
tivities, anti-atherosclerotic, anti-tumor and anti-mutagenic
activity [8, 9].
Diabetes is a pandemic endocrine disorder character-
ized by hyperglycemia resulting from insulin resistance
or overall insulin dysfunction [10, 11]. Modern synthetic
hypoglycemic agents can cause side effects, are costly
and decline in efficiency with long term uses [12, 13].
The inhibition of the α-glucosidase enzyme can control
the intestinal carbohydrate metabolism by retarding the
cleavage of polysaccharides to glucose [14, 15]. There-
fore, the best strategy is to reduce the postprandial up-
surge of blood glucose level and prevent late diabetic
complications. Thus natural product based α-glucosidase
inhibitors are the key targets to identify new compounds
for the therapeutic management of diabetes [16]. The
extensive literature reported more than four hundred
natural products isolated from various herbal plants that
exhibited digestive enzyme inhibitory activity [17], a ma-
jority of the compounds were flavonoid, terpene, and
phenylpropanoid ring containing compounds [17].
Clinacanthus nutans Lindau is a medicinal plant from
Acantheceae family widely distributed throughout tropical
Asia. For a long time, this shrub has been used to prevent
skin infections, insect bites and lesions caused by the herpes
simplex and varicella-zoster viruses [18, 19]. Many beneficial
effects of this plant have been reported, including antidia-
betic, antioxidant, anti-proliferative, immunomodulatory,
wound healing, anti-inflammatory, analgesic activities and
anti-viral activities [20–23]. However, its efficacy is yet to be
proven scientifically and more research needs to be carried
out, especially with regard to the antidiabetic effects of this
plant. Our analysis of the current literature ascertained that-
the free radical scavenging activity, ferric reducing antioxi-
dant power, and α-glucosidase inhibitory activity of the
methanol extract and its different polar, non-polar fractions
from C. nutans have not been previously determined.
Moreover, the complete phytochemical profile of this plant
remains unestablished. Therefore, this study aimed to inves-
tigate the in vitro antioxidant and α-glucosidase inhibitory
activities of methanol extract and its different fractions from
C. nutans. Our research also identified the various chemical
constituents of the extract and fractions by GC Q-TOF MS,
in addition to bioactivity correlation.
Methods
Sample collection and preparation
The stem of C. nutans was obtained from TKC Herbal
Nursery SDN BHD, Pusat Pertanian Pantai Baru, Pantai
Negeri Sembilan, Malaysia in September 2014. The plant
material was identified by Dr. Alfi Khatib, Associate
Professor, Department of Pharmaceutical Chemistry, Inter-
national Islamic University, Kuantan, Pahang, Malaysia. A
voucher specimen (PIIUM 0238–1) was deposited in the
herbarium of the Faculty of Pharmacy, International Islamic
University, Kuantan, Pahang, Malaysia. The C. nutans stem
was dried, in an airy place under shade. When dry the sam-
ples were ground in a cutting mill (FRITSCH, Pulverisette
19, Germany), sieved, and fractionated by a vibratory sieve
shaker (AS 700, BASIC, RETSCH, Germany) to obtain fine
particles. The extracts and fractions were freeze dried
before analysis of the pharmacological activity and chemical
profile (Alpha 1–2 LD plus CHRIST, Freeze dryer, UK).
Chemicals
Ethanol (99.5%, analytical grade), Folin-Ciocalteu phenol
reagent, potassium acetate, aluminum chloride, sodium car-
bonate, methanol, hexane, ethyl acetate and butanol were
obtained from Merck Germany (Darmstadt, Germany). α-
Glucosidase enzyme (Saccharomyces cerevisiae) and 4-
nitrophenyl β-D-glucopyranoside substrate were obtained
from the Sigma Chemical Co (St. Louis, Mo., U. S. A.). 2, 2-
Diphenyl-1-picrylhydrazyl (DPPH), methoxyamine hydro-
chloride, pyridine, N-Methyl-N-(trimethylsilyl) trifluoroace-
tamide, quercetin (≥95% HPLC, solid), and rutin hydrate
(≥94% HPLC, powder) were obtained from Malaysia
Sigma-Aldrich (M), Sdn. Bhd. Kuala Lumpur, Malaysia. All
other chemicals used were of analytical grade.
Extraction and fractionation
The solvent extraction of the air-dried stem of C. nutans
was performed by maceration technique using methanol as
the initial solvent in an Erlenmeyer flask. After maceration,
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the mixture was sonicated for 15 min, and set aside for
24 h, filtered, and evaporated in a rotary evaporator at 40 °
C under reduced pressure. The extract was freeze dried and
stored ready for pharmacological analysis and fractionation.
The fractionation of dried methanolic extract was
achieved by liquid-liquid partition chromatography in a
separating funnel using hexane, methanol, and water
(13:2:5) with a final volume of 2 L, based on the amount
of extract. After vigorous shaking, the mixture was set
aside until two layers were formed. To obtain the hexane
fraction, the was separated and then concentrated in rotary
evaporator at 40 °C under reduced pressure. To obtain the
ethyl acetate fraction, the remaining fraction in the separat-
ing funnel was added to ethyl acetate and the evaporation
procedure was repeated. Similarly, butanol was added to
obtain the butanol fraction; the remaining material in the
separating funnel was considered as the residual aqueous
fraction. The residual solvent was removed from the extract
and fractions by freeze drying. The methanol extract and its
four fractions were then freeze-dried and stored at −80 °C
freezer until use.
Total phenolic content
The total phenolic content (TPC) of the methanol extract
and the derived fractions from C. nutans were determined
spectrophotometrically according to the Folin-Ciocalteu
method [24]. The reaction mixture was prepared by mixing
20 μL of the extract solution (at 5 mg/mL in DMSO),
100 μL Folin-Ciocalteu reagent (1 mL of Folin-Ciocalteu re-
agent in 9 mL of distilled water) and 80 μL 7.5% Na2CO3
solution in deionized water. The solution was incubated for
30 min in a dark place at 26.8 °C and the absorbance was
measured at 765 nm. The total phenolic concentration was
calculated from a gallic acid (GA) calibration curve 10–
100 mg/L; y = 0.0005x + 0.0779, R2 = 0.9943. Data were
expressed as gallic acid equivalent/g of extract averaged
from three measurements.
Total flavonoid content
The total flavonoid content (TFC) of the C. nutans extract
and fractions were estimated according to the aluminum
chloride spectrophotometric method based on the forma-
tion of aluminum-flavonoid complexes [25]. To prepare the
reaction solutions, approximately 2 mL extract solution
(0.3 mg in 1 mL of methanol), 0.1 mL aluminum chloride
hexahydrate solution (10% aqueous AlCl3 solution), 0.1 mL
1 M potassium acetate and 2.8 mL of deionized water were
mixed together. The mixture was shaken and incubated at
26.8 °C for 10 min. After incubation, the solution was sub-
jected to spectral analysis at 415 nm. A standard curve was
constructed of the absorbance of rutin between 0.005 and
0.1 mg/mL and the total flavonoid content calculated as
mg rutin equivalent per g dry extract. The absorbance at
415 nm = 14.171x + 0.0461, R2 = 0.9991.
DPPH free radical scavenging activity
The free radical scavenging capacity of the methanol extract
and each derived fractions from C. nutans were analyzed
by using a 96-well microplate and 2, 2-diphenyl-1-picrylhy-
drazyl (DPPH) as the free radical source [26]. For sample
preparation, 5 mg freeze dried sample was added to 1 mL
of DMSO, which was vortexed and sonicated to produce a
homogenized solution. The sample solution was transferred
(100 μL) to a 96well plate and 50 μL of this sample was di-
luted with 50 μL DMSO. Then, 100 μL DPPH (5.9 mg in
100 mL 100% ethanol) was added to each of dilutions, sus-
pended and incubated in a dark place for 30 min. Blank
samples were prepared following the same procedure, but
used using 100 μL 100% ethanol instead of DPPH. A re-
agent blank which contained 50 μL DMSO and 100 μL
DPPH, but no sample was, also subjected to the sample
preparation process. Quercetin was used as a positive con-
trol to observe the reaction of inhibition. The absorbance
was recorded at 517 nm and the percentage inhibition was
calculated by using the following equation-
%Inhibition ¼ Rb− Sa−BSað Þ
Rb
 100 ð1Þ
Rb = Reagent blank absorbance
Sa = Sample absorbance
BSa = Blank sample absorbance
Ferric reducing antioxidant power assay
The total antioxidant capacity of methanol extract and
other derived fractions were examined by using the
FRAP method adapted by Szd lowska Czerniak et al.,
with some modifications [27]. FRAP reagent (10 mM
TPTZ solution) (2.5 mL) in 40 mM HCl, 20 mM FeCl3
(2.5 mL), and 0.1 M acetate buffer pH 3.6 (25 mL) was
freshly prepared and incubated for 10 min at 37 °C in an
oven. Then 20 μL of different concentration (0%, 20%,
40%, 60%, 80% and 100%) of methanol extract and frac-
tions of C. nutans and ascorbic acid (standard) and
40 μL FRAP reagent were added to 140 μL of distilled
water in a 96 wells plate. The samples were stored at
26.8 °C for 20 min in dark and the blue color was quanti-
fied through measurement of the absorbance at 593 nm
relative to a reagent blank (40 μL FRAP reagents and
160 μL distilled water) using microplate reader. Ascorbic
acid was used as a standard compound to create a calibra-
tion curve. The total antioxidant capacity of the samples
was expressed in ascorbic acid equivalents as (AAE) in μg/
g of dried sample.
α-Glucosidase inhibitory assay
The α-glucosidase inhibitory activity of the C. nutans ex-
tract and each of the fractions from liquid-liquid partition
chromatography was determined following the method by
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Collins et al., [28]. In this assay, the formation of p-nitro-
phenol that resulted from the cleavage of p-nitrophenyl-α-
D-glucopyranose was estimated for the evaluation of α-
glucosidase inhibitory activity. To prepare the stock solu-
tion, 5 mg of the extract and fractions were dissolved in
1 mL of DMSO. Additionally, 5 mg quercetin was dis-
solved in 1 mL of DMSO to form a positive control [29].
For the dilution, 10 μL prepared stock solutions were
added to 115 μL 30 mM phosphate buffer (pH 6.5). The
enzyme (α-glucosidase type 1 from Saccharomyces cerevi-
siae) (Sigma G5003) solution was prepared using 1 mg en-
zyme with 13.9 mL 50 mM phosphate buffer (pH 6.5).
The substrate containing 3 mg p-nitrophenyl-α- D-
glucopyranose (Sigma-Aldrich, N1377-1G) was dissolved
in 10 mL of a 50 mM phosphate buffer (pH 6.5) and incu-
bated at 26.8 °C for 15 min. The diluted samples were
mixed with 15 μL of enzyme and 75 μL of substrate in the
microplate, and incubated for 15 min at 26.8 °C. A blank
sample, positive control, negative control, and blank posi-
tive control were prepared according to the mentioned
method. Glycine solution was prepared as a reaction-
stopping reagent by the dissolution of 15 g with 100 mL
of cold water (pH 10). The optical densities (ODs) were
read at 405 nm in a multi-detection micro-plate reader
(Infinite M200, Tecan, Switzerland) [30]. The inhibitory
activity was calculated according to the following equation
%Inhibition of sample ¼ an−as
an
 100 ð2Þ
where an = negative control and ap = (Sample Absorbance-
Blank Sample Absorbance).
Derivatization for GC Q-TOF MS analysis
Derivatization of the methanol extract and the derived
polar-nonpolar fractions from C. nutans were performed
by methoxyamination and trimethylsilylation (TMS) for
GC Q-TOF MS chemical profiling according to the
method mentioned by Robinson et al. [31]. The methox-
yamine hydrochloride was dissolved in pyridine to pro-
duce a concentration of 20 mg/mL. Exactly 2.5 mg of
sample was mixed with 50 μL pyridine in a 2-mL centri-
fuge tube and sonicated for 10 min at 30 °C. Then, 100 μL
methoxyamine hydrochloride (20 mg/mL in pyridine) was
added to the sample solution and incubated for 2 h at 60 °
C. After the incubation 300 μL MSTFA (N-Methyl-N-(tri-
methylsilyl) trifluoroacetamide) was mixed and incubated
for a further 30 min at 60 °C. The prepared sample was
stored overnight at 23 °C for the completion of chemical
reaction. The mixture was then filtered by syringe filter
for the separation of any solid particles.
GC Q-TOF MS determination
The GC-MS Agilent system of model 7200 accurate-mass
GC QTOF equipped with a 7890A GC system connected
to a detector quadrupole time of flight mass spectrometer
was used to acquire mass spectral data. Exactly, 1 μL of
derivatized sample was injected into the inlet of the Agilent
GC column (J &W Scientific, Folsom, CA, USA) model,
HP-5MS; dimensions 30 m × 0.25 mm × 0.25 μm), with
50:1 split mode and ratio. The injector temperature was
maintained at 280 °C and the detector was maintained at
290 °C. The oven temperature profile was as follows: an in-
crease from set to 70 to 135 °C with a 2 °C/min, hold for
10 min, an increase from 135 to 220 °C with 4 °C/min, hold
for 10 min, an increase from 220 to 270 °C at 3.5 °C/min
and then a final hold for 20 min. Helium was used as car-
rier gas at a constant flow rate of 1.9 mL/min. GC Q-TOF
MS, and Auto MS-MS data were processed with Mass
Hunter qualitative analysis software (v. B.06.00 SP1, Agilent
Technologies Inc., USA). Agilent Mass Profiler Professional
(MPP) software was used to eliminate the molecular
features produce from background by deduction of data
from the blank spectrum. The mass spectral deconvolution
was performed by Mass Hunter Unknown Analysis Soft-
ware (version B.06.00) which automatically detected peaks
and deconvoluted the spectra using model ion traces.
Statistical analysis
The results were calculated as the mean ± SD from three
separate experiments (n = 3). The IC50 values of the extract
and fractions for DPPH free radical scavenging and α-
glucosidase inhibitory activity were determined by Graph
Pad Prism 5 software. The significant differences between
the means were established by ANOVA with Bonferroni
post tests and Newman-Keuls multiple comparison test.
Values of P < 0.05 were considered statistically significant.
Results
Yield
The average yield of methanol extract from solvent extraction
by the maceration technique was found to be 12.63 ± 0.98
(as % w/w of C. nutans on a dry weight basis). The fraction-
ation of methanolic extract produced the hexane, ethyl acet-
ate, butanol, and residual aqueous fractions with average
yields of 29.08 ± 0.070, 1.23 ± 0.03, 8.558 ± 0.0305 and
52.25 ± 1.013 (as the percentage of total methanol extract;
the white precipitation from the butanol fraction was
excluded from this study), respectively (Table 1).
Total phenolic content (TPC) and total flavonoid content
(TFC)
The total phenolic content of the extract and all the frac-
tions were, reported as gallic acid equivalents per g of
dried sample. The TPC of the methanol extract was
7.54 ± 0.02 mg GAE/g, whereas the ethyl acetate fraction
had the highest TPC (17.403 ± 0.025 mg GAE/g) among
all the fractions. The methanolic extract had a TFC of
16.83 ± 0.085 mg Rutin Equivalent/g of dried materials
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and the hexane fraction contained the maximum TFC
(22.78 ± 0.01 mg RE/g) compared with all other fractions.
The TPC and TFC of methanolic extract and the different
fractions are presented in Table 1.
DPPH free radical scavenging activity
The DPPH free radical scavenging is a commonly used
method to assess antioxidant activity in plant samples.
The antioxidant activity of the samples was examined at
six different concentrations (31.25, 62.5, 125, 250, 500 and
1000 μg/mL). In this study, all the samples dose- depend-
ently scavenged DPPH radicals, except for the residual
aqueous fraction. The ethyl acetate fraction showed the
highest DPPH scavenging activity, at 79.98 ± 0.31% (IC50:
0.2691 mg/mL) whereas the lowest scavenging ability was
observed in the methanol extract, at 63.07 ± 0.118%
(IC50: 0.3302 mg/mL). The antioxidant activity of the
methanol extract and its derived fractions was ranked as
follows: ethyl acetate > butanol > hexane > methanol > re-
sidual aqueous fraction. The DPPH free radical scavenging
activity at different concentration of methanol extract and
fractions is shown in Fig. 1.
Ferric reducing antioxidant power assay
The donation of electrons by the reduction of ferric cyan-
ide complex in the ferrous form specifies the reducing
capacity of experimental samples. Essentially, this method
considers the total antioxidant capacity of a sample
through the oxidation-reduction potential. The methanol
extract and ethyl acetate fraction exhibited the highest
FRAP values of 141.89 ± 0.874 and 133.6 ± 0.29 AAE μg/g
respectively (Table 2). The reducing power of the extract
and fractions was ranked as follows: methanol > ethyl
acetate > butanol > hexane > residual aqueous.
α-Glucosidase inhibitory activity
The α-glucosidase inhibitory activity of the methanol ex-
tract and the fractions was assessed at six different dilu-
tions (6.25, 12.5, 25, 50, 100 and 200 μg/mL) (Fig. 2).
The highest potential α-glucosidase inhibitory activities
were found in the butanol and ethyl acetate fractions
with inhibition of 72.16 ± 1.0041% (IC50: 37.47 μg/mL)
and 70.76 ± 0.4974% (IC50: 53.69 μg/mL) (Table 2). The
efficacy of the α-glucosidase inhibition of the extract and
various fractions was ranked as follows: butanol > ethyl
acetate > hexane > methanol > residual aqueous. The
standard quercetin was used as positive control and
showed a maximum α-glucosidase inhibitory activity of
94.63 ± 1.21% (IC50: 38.54 μg/mL).
GC Q-TOF MS analysis
GC Q-TOF MS analysis was conducted to identify the
phytoconstituents of the methanol extract and the four
fractions. The spectral data were integrated with mass
retention index of NIST14.L library. This study only
considered those compounds with matching library
scores with similarity index of 70%. The biological po-
tential of the identified compounds was compared with
previously reported results (Table 3). The major phyto-
chemicals were found in the methanol extract and the
fractions, except residual aqueous. The identified phyto-
chemicals belonged mainly to the classes of α-hydroxyl
Table 1 Total yield, total phenolic content and total flavonoid
content of methanol extract and its different fractions
Yield% TPC (mg GAE/g) TFC (mg RE/g)
Methanol 12.63 ± 0.92 7.54 ± 0.52 16.83 ± 0.85
Hexane 29.08 ± 0.70 13.31 ± 0.36 22.78 ± 0.10
Ethyl Acetate 1.23 ± 0.03 17.403 ± 0.25 13.29 ± 0.04
Butanol 8.558 ± 0.30 4.105 ± 0.75 10.04 ± 0.56
R. Aqueous 52.25 ± 1.01 1.32 ± 0.02 9.53 ± 0.088
Each value in the table is represented as mean ± SD (n = 3)
Fig. 1 DPPH Free Radical Scavenging Activity at Different Concentration
of Methanol Extract and its Fractions. The IC50 values of Methanol Extract
and its Hexane, EoAC, BuOH, R. aqueous Fractions are 0.3302 mg/ml,
0.1527 mg/ml, 0.2691 mg/ml, 0.2517 mg/ml, 0.585 mg/ml and
0.1927 mg/ml, respectively. Legends: MeOH, Hexane, EoAC,
BuOH, R. Aqueous, Quercitin
Table 2 DPPH scavenging activity, ferric reducing antioxidant
power and α-Glucosidase inhibitory activity of methanol extract
and its different fractions
DPPH% FRAP (μg AAE/g) AGI%
Methanol 63.07 ± 0.11a 141.89 ± 3.87**/* 58.21 ± 0.8a
Hexane 66.35 ± 0.09b 130.56 ± 2.43*/* 69.94 ± 0.81b
Ethyl Acetate 79.98 ± 0.31c 133.6 ± 3.29*/* 70.76 ± 0.49c
Butanol 78.47 ± 0.26c 132.76 ± 3.72**/* 72.16 ± 1.12d
R. Aqueous 28.32 ± 0.27d 12.11 ± 0.31ns 41.86 ± 0.37e
Each value in the table is represented as mean ± SD (n = 3). Means within
each column with different letters (a-e) differ significantly (p < 0.05) according
to ANOVA with Newman-keuls multiple comparison test when compared with
standard. For FRAP compared total phenolic and total flavonoid content where
**P < 0.01, *P < 0.05, nsP > 0.05 according to ANOVA with Bonferroni posttests
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acids, dicarboxylic acids, terpenes, phenolics, inositols,
fatty acids, coumarins, glycosides, phytosterols, polysi-
loxanes and polyols. The phytochemical profiling of C.
nutans revealed that experimental samples were abun-
dant in the phenolic and terpenoids compounds.
Discussion
In the current study, we fractionated the crude extract of C.
nutans using polar and non-polar solvents to obtain phyto-
constituent rich biologically active standardized fractions
and produced a comprehensive metabolite profiling. The
average yield, TPC, and TFC of different samples are pre-
sented in Table 1. In order to achieve high quality fraction-
ation, the purification of the extract essentially be purified
to remove undesirable components could, enhance the bio-
logical activity for future pharmaceutical applications.
Therefore, it is crucial to select an appropriate extraction
process, as affects the characterization of secondary metab-
olites [32]. Plant phenolics are one of the most abundant
vital group of phytochemicals and are widely known for
their antioxidant and radical scavenging activity with poten-
tial impacts on human health. The phenolics are natural
antioxidants which can control oxidative stress-related de-
generative diseases. The adverse effects of oxidative stress
have been found to be controlled by the antioxidant activ-
ities of this group of bioactive compounds. Therefore, nu-
merous experimental studies have been designed to
elucidate the antioxidant and other activities of these com-
pounds that can inhibit certain pathological and degenera-
tive complications [33].
As presented in Fig. 1, dose-dependent DPPH radical
scavenging capacity was examined in the methanol ex-
tract and fractions, in which the standard compound
(quercetin) produced the maximum antioxidant activity
(IC50: 0.1927 mg/mL). The methanol extract, hexane
and residual aqueous fractions were statistically signifi-
cant when compared with quercetin (Table 2). This re-
search work also revealed a strong agreement between
the antioxidant activity of samples when measured by
the TPC and TFC. Among all the fractions, the ethyl
acetate fraction had the highest DPPH free radical scav-
enging activity and was rich in phenolic and flavonoid
content (P < 0.05) (Table 2). The TPC, TFC of butanol,
and TPC of the hexane fraction also shown a significant
correlation with antioxidant activity (P < 0.05) (Fig. 3).
Hence, these findings support the antioxidant function
of phenolics and are also in good agreement with previ-
ous research [34].
To determine the reducing power, the ferric reducing anti-
oxidant power (FRAP), was studied for the methanol extract
and the fractions of C. nutans to determine the reducing
power; this provides a substantial indicator of antioxidant
capacity. The presence of reducing agents in the samples is
associated with the exertion of antioxidant activity by the
cleavage of free radical chains through the donation of
hydrogen atom. The statistically significant TPC and TFC
values (P < 0.05), showed a positive correlation with the
FRAP of methanol extract and fractions, except for the re-
sidual aqueous (Table 2). The methanol extract showed the
highest reducing power, with a value of 141.89 ± 0.87 μg
AAE/g followed by the ethyl acetate (133.6 ± 0.29), butanol
(132.76 ± 0.72), hexane (130.56 ± 0.43) fractions.
An effective approach for the management of carbohy-
drate metabolic disorders, including diabetes mellitus
type II is the inhibition of the α-glucosidase enzyme
[35]. A delay in the digestion of carbohydrate plays an
important role in the control of postprandial hypergly-
cemia, hyper insulinemia and decreases the risk of car-
diovascular disease [36]. The α-glucosidase inhibitory
activity of the methanol extract and fractions were sig-
nificantly to the standard compound (Table 2).
Natural bioactive compounds regulate blood glucose level
through obstructing the degradation of polysaccharides
[37]. Plant phenolics are natural α-glucosidase inhibitors
because they inhibit intestinal carbohydrate digesting
enzymes owing to their protein-binding capability [38].
Recent researchers have reported the α-glucosidase inhibi-
tory activity of numerous flavonoid compounds [39]. As
shown in Fig. 2, the α-glucosidase inhibitory activity of
methanol extract and the obtained fractions were evaluated
at different concentrations: the strongest inhibitory concen-
tration (IC50 37.47 μg/mL) was found in the butanol
fraction compared with the standard compound. A multiple
range test, between the extract, fractions and positive
control is shown in Table 2; the extract and fractions were
significantly different from the control (P < 0.05).
The current study also revealed a significant (P < 0.05) cor-
relation between the TPC and TFC with an α-glucosidase
Fig. 2 α-Glucosidase Inhibitory Activity at Different Concentration of
Methanol Extract and its Fractions. The IC50 values of Methanol
Extract and its Hexane, EoAC, BuOH, R. aqueous Fractions are
0.06139 mg/ml, 0.04457 mg/ml, 0.05369 mg/ml, 0.3747 mg/ml,
0.0635 mg/ml and 0.03854 mg/ml, Respectively. Legends: MeOH,
Hexane, EoAC, BuOH, R. Aqueous, Quercitin
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Table 3 Identified metabolites in methanol extract and its different fractions
MeOH Mass Formula (DB) Score (Lib) m/z RT
Glyceric acid rq 322.145 C12H30O4 82.1 73.03153 22.04
Malic acid hex, rq 350.14 C13H30O 82.63 73.03153 31.411
Erythritol hex, bu., rq 410.216 C16H42O4 83.96 73.03153 33.044
Ribitol hex 512.266 C20H52O5 90.44 73.03153 49.243
Neophytadiene 278.297 C20H38 81.5 67.0393 53.357
Mannitol bu 614.316 C24H62O6 86.43 73.03153 56.957
Gluconic acid 628.295 C24H60O7 72.71 73.03153 58.972
Palmitic acid rq 328.28 C19H40O2 75.99 117.0168 59.131
Rhamnose ea., bu., rq 452.227 C18H44O5 71.07 73.03153 59.918
Myo-Inositol hex, ea., bu 612.301 C24H60O6 81.27 73.03153 61.069
Oleic Acid hex 354.295 C21H42O2 74.58 75.01034 63.292
Stearic acid hex, ea., bu., rq 356.311 C21H44O2 75.89 117.0168 63.921
1-Monopalmitin hex, ea., bu., rq 474.356 C25H54O4 86.25 371.2661 76.818
Hexane Mass Formula (DB) Score (Lib) m/z RT
Glycolic acid ea., bu., rq 220.095 C8H20O3 78.81 147.0445 8.457
Glycerol hex, bu 308.166 C12H32O3 86.8 73.03193 18.785
Myristic acid 300.248 C17H36O2 77.37 117.0175 53.071
Hexadecanoic acid bu 270.256 C17H34O2 80.98 87.02704 55.509
Cyclononasiloxane ea., bu 666.169 C18H54O9 78.42 73.03193 64.886
Squalene 410.391 C30H50 76.25 81.05419 83.616
Sulfurous acid 376.301 C21H44O3 79.63 57.05663 85.537
β-Tocopherol 488.405 C31H56O2 78.3 488.3697 87.803
1-Tetracosanol 426.426 C27H58O 74.64 411.3688 87.824
γ-Tocopherol 488.405 C31H56O2 76.32 73.03193 88.004
Lupeol 426.386 C30H50O 78.1 189.1404 98.854
EoAC Mass Formula (DB) Score (Lib) m/z RT
Lactic Acid rq 234.111 C9H22O3 70.76 73.03193 7.867
Hexanoic acid 188.123 C9H20O2 82.18 73.03193 8.127
Oxalic acid 234.074 C8H18O4 74.24 147.0437 11.408
Benzoic acid 194.076 C10H14O2 89.19 135.0956 16.142
Benzeneacetic acid 208.092 C11H16O2 82.37 73.03193 19.06
Tyrosol 282.147 C14H26O2 83.45 179.063 35.281
Arabinitol bu., rq 512.266 C20H52O5 87.01 73.03193 49.249
Vanillic acid 312.121 C14H24O4 81.66 297.1034 49.77
4-Coumaric acid 308.126 C15H24O3 81.65 293.1079 50.764
p-Coumaric alcohol 294.147 C15H26O2 75.26 73.03193 51.005
Azelaic acid 332.184 C15H32O4 85.4 73.03193 51.378
Tryptophol 305.163 C16H27NO 73.32 202.1438 54.561
Syringic acid 342.132 C15H26O5 76.23 327.0037 55.145
Heptasiloxane 532.184 C16H48O6 70.08 355.0375 87.993
D-Xylose bu 438.211 C17H42O5 74.23 191.0664 88.537
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inhibitory activity of the samples (Fig. 4). The higher con-
centration phenolics, flavonoids and higher antioxidant
activity, resulted in a higher enzyme inhibitory capacity
(Table 2). The results from the current study are in good
agreement with other research works, which have re-
ported the ability of phenolic rich extracts that exhibited a
high antioxidant and α-glucosidase inhibitory effect [40].
Furthermore, these results revealed a direct correlation
between antioxidant activity and α-glucosidase inhibitory
activity. Butanol, ethyl acetate and hexane fractions re-
vealed similar α-glucosidase inhibitory activities of 72.16
± 1.0041%, 70.76 ± 0.4974% and 69.94 ± 0.8115% whereas
the methanol extract showed moderate inhibitory activity
58.21 ± 0.08%. The butanol fraction had significantly
higher (P < 0.05) α-glucosidase inhibitory activity, with an
IC50 value of 37.47 μg/mL, which is close to the standard
quercetin compound (IC50: 38.54 μg/mL). The higher
phytochemical content and antioxidant activity signifi-
cantly influenced the α-glucosidase inhibitory activity of
the samples (P < 0.05).
The most abundant identified phytoconstituents were
neophytadiene, squalene, lupeol, tocopherols, vanillic acid,
syringic acid, myo-inositol, glycolic acid, butanedioic acid,
4-coumaric acid, and stigmasterol. Extensive literature
searches documented that the identified compounds were
responsible for various biological activities, including anti-
oxidants, antidiabetic, and anti-inflammatory chemothera-
peutic agents [41]. The structural orientation of the
polyphenolic compounds owing to the lactones/quinones
or 4-oxo-pyrane moiety responsible for the digestive en-
zyme inhibitory activity [42]. It was also reported that
phenolic compounds help to reduce the intestinal digestive
enzymes and were able to oxidize the body fat owing to
their thermogenic properties [43], whereas the terpenes
and terpenoids class of compounds can act as anti-
hyperglycemic agents [44].
Conclusion
The methanol extract of C. nutans and the obtained solvent
fractions exhibited a significant range of biological activities.
The ethyl acetate and butanol fractions of the methanol ex-
tract had the highest antioxidant and α-glucosidase inhibi-
tory activity which showed a significant correlation with the
total phenolic and total flavonoid contents of the fractions.
Table 3 Identified metabolites in methanol extract and its different fractions (Continued)
BuOH Mass Formula (DB) Score (Lib) m/z RT
Propylene glycol 220.131 C9H24O2 72.85 73.03256 13.928
Dulcitol 614.316 C24H62O6 73.74 73.03256 56.96
Octadecanoic acid 284.272 C18H36O2 71.73 87.02775 62.021
Residual Aqueous Mass Formula (DB) Score (Lib) m/z RT
Butanedioic acid 262.106 C10H22O4 78.34 147.0448 20.507
Xylitol 512.266 C20H52O5 75.32 73.0321 49.24
Subscript with hex-hexane fraction, ea.- ethyl acetate fraction, bu.-butanol fraction, rq-residual aqueous fraction represents the identified compound in
that fraction
Fig. 3 Effect of TPC and TFC on DPPH Free Radical Scavenging
Activity. Bars with **P < 0.01, *P < 0.05 are Significantly Correlated
whereas nsP > 0.05 Denotes Non significant Correlation According to
Bonferroni Posttests (The Numerator on Bar Represent the
Correlation with TPC and Denominator with TFC)
Fig. 4 Effect of TPC and TFC on α-Glucosidase Inhibitory Activity.
Bars with ***P < 0.01, **P < 0.01, *P < 0.05 are Significantly
Correlated whereas ns P > 0.05 Denotes Non significant Correlation
According to Bonferroni Posttests (The Numerator on Bar Represent
the Correlation with TPC and Denominator with TFC)
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In addition, there was a strong correlation of the antioxidant
activity with the α-glucosidase inhibitory potency of different
samples. GC Q-TOF MS analysis showed that the presence
of major phytoconstituents might be responsible for the po-
tential antioxidant and α-glucosidase inhibitory activities of
C. nutans extract and fractions. However, further toxico-
logical study of the antioxidant rich fractions is necessary to
verify their suitability for future pharmaceutical applications.
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